• Home
  • About
  • Contact Us
  • Home
  • About
  • Contact Us
Up and Down the Ladder: Job Changes… The latest comings and goings…
October 30, 2015 9:34 AM
thx to futundbiedl on flickr creative commons

thx to futundbiedl on flickr creative commons

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Baxter International hired Jose Almeida as chief executive officer, effective Jan. 1. Previously, he was ceo at Covidien, which was recently sold to Medtronic for $50 billion. During his tenure there, he carved out the generic drug business to focus on devices and surgical tools.

Mylan hired Ranjan Ray Chaudhuri to as global commercial head of its over-the-counter business;

Roche moved Richard Erwin from Belgium to head its UK operations;

Bellicum Pharmaceuticals hired Alan Smith as senior vp of manufacturing;

Mirna Therapeutics hired Miguel Barbosa as exec vp and chief scientific officer;

Astellas promoted Doug Geiger to vp, head of new therapeutic areas, marketing strategy;

Aqua Pharmaceutical promoted Ted White to president and general manager;

BioTime promoted Adi Mohanty to co-chief executive officer;

Sorrento Therapeutics hired Jeffrey Sue as exec vp and chief operating officer;

Anika Therapeutics hired Richard Hague as chief commercial officer;

Trinity Partners added Nason Russ as a senior consultant;

Print This Post Print This Post
Anika TherapeuticsAqua PharmaceuticalAstellasBaxter InternationalBellicum PharmaceuticalsBioTimeMirna TherapeuticsMylanRocheSorrento TherapeuticsTrinity Partners
Share

Executive Hiring

Ed Silverman

You might also like

Up and Down the Ladder: Job changes.. The latest comings and goings
November 13, 2015
Pharmalot.. Pharmalittle.. As the weekend nears.. Catching up on Merck, Roche and..
November 13, 2015
Pharmalot.. Pharmalittle.. Good Morning.. Catching up on Valeant, Allergan, Novartis and..
November 11, 2015
  • About Pharmalot

    Pharmalot is produced by Stat, a national publication from Boston Globe Media Partners that will launch online this fall with coverage of health, medicine and life sciences. Learn more and sign up for exclusive content at www.statnews.com, where Pharmalot will move after the launch.

    Ed Silverman, a senior writer at Stat, has covered the pharmaceutical industry for two decades and has closely followed the many hurdles facing drug makers as they move ideas from the laboratory to the medicine chest. He has previously worked at The Wall Street Journal, The Star-Ledger of New Jersey, New York Newsday and Investor’s Business Daily. Feel free to send tips and suggestions to ed.silverman@statnews.com Follow us on Twitter @Pharmalot and @StatNews. And sign up for the Stat newsletter here.
  • Categories

    • AIDS
    • Alzheimer's
    • Antibiotics
    • Antitrust
    • Biosimilars
    • Bribes
    • Cancer
    • Cholesterol
    • Clinical Trials
    • Compound Pharmacies
    • Counterfeit Medicines
    • Diabetes
    • Direct-to-Consumer Advertising
    • Drug Development
    • Executive Hiring
    • FDA
    • FTC
    • Generics
    • Hepatitis C
    • Insider Trading
    • Laboratory Tests
    • Layoffs
    • Legislation
    • Litigation
    • Marketing
    • Medicaid
    • Mergers and Acquisitions
    • Off-Label Promotion
    • Off-Label Promotoin
    • Over-the-Counter Medicines
    • Painkillers
    • Patents
    • Patient Privacy
    • Patient Safety
    • Pharmacy Benefit Managers
    • Pricing & Patient Access
    • Product Recall
    • Quality Control
    • Rare Diseases
    • Research & Development
    • Schizophrenia
    • Side Effects
    • Uncategorized
    • Vaccines
    • Whistleblower


© Copyright Pharmalot 2015. All Rights Reserved.